niacinamide and pd 0325901

niacinamide has been researched along with pd 0325901 in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (22.22)	29.6817
2010's	7 (77.78)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lyons, J; Thompson, N	1
Clemetson, KJ	1
Abrams, SL; Andreeff, M; Bergamo, P; Chiaretti, S; Ciuffreda, L; Cognetti, F; Del Bufalo, D; Foà, R; Konopleva, M; Marchetti, A; Mascolo, MG; McCubrey, JA; Milella, M; Petrucci, MT; Ricciardi, MR; Scerpa, MC; Steelman, LS; Tafuri, A; Tavolaro, S; Tsao, T	1
Bouzin, C; Calderon, PB; Charette, N; Danhier, P; Feron, O; Gallez, B; Grégoire, V; Jordan, BF; Karroum, O; Kengen, J; Magat, J; Mignion, L; Sonveaux, P; Starkel, P; Verrax, J	1
Andersen, NJ; Baker, LH; Boguslawski, EA; Dawes, MJ; Duesbery, NS; Dykema, KJ; Froman, RE; Furge, KA; Kamstock, DA; Kitchell, BE; Krivochenitser, RI; Nickoloff, BJ; Thomas, DG	1
Bandyopadhyay, S; Burlingame, AL; Gordan, JD; Hann, B; Levin, RS; McCormick, F; Oses-Prieto, JA; Salt, M; Shokat, KM; Sos, ML; Webber, JT	1
Wu, CH; Wu, X; Zhang, HW	1
Bruner, JK; Jones, RJ; Levis, MJ; Li, L; Ma, HS; Pratilas, CA; Pratz, KW; Qin, ACR; Rudek, MA; Small, D	1
Barney, LE; Hall, CL; Jansen, LE; Meyer, AS; Nguyen, TV; Peyton, SR; Schwartz, AD	1

Reviews

1 review(s) available for niacinamide and pd 0325901

Article	Year
Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery. Current opinion in pharmacology, 2005, Volume: 5, Issue:4 Topics: Animals; Benzamides; Benzenesulfonates; Clinical Trials as Topic; Diphenylamine; Extracellular Signal-Regulated MAP Kinases; Humans; Molecular Structure; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-raf; Pyridines; Signal Transduction; Sorafenib	2005

Article

Year

Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery.

Current opinion in pharmacology, 2005, Volume: 5, Issue:4

Topics: Animals; Benzamides; Benzenesulfonates; Clinical Trials as Topic; Diphenylamine; Extracellular Signal-Regulated MAP Kinases; Humans; Molecular Structure; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-raf; Pyridines; Signal Transduction; Sorafenib

2005

Other Studies

8 other study(ies) available for niacinamide and pd 0325901

Article	Year
American Society of Hematology--48th Annual Meeting and Exposition. Updates on therapies. 9-12 December 2006 Orlando, FL, USA. IDrugs : the investigational drugs journal, 2007, Volume: 10, Issue:2 Topics: Anemia, Sickle Cell; Antibiotics, Antineoplastic; Antigens, CD20; Benzamides; Benzenesulfonates; CD40 Antigens; Diphenylamine; Hematologic Neoplasms; Hematology; Humans; Ki-1 Antigen; Leukemia, Myeloid; Lymphoma; MAP Kinase Kinase Kinases; Niacinamide; Phenylurea Compounds; Pyridines; Sirolimus; Sorafenib	2007
Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for "vertical" and "lateral" combination strategies. Journal of molecular medicine (Berlin, Germany), 2012, Volume: 90, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Benzamides; Benzenesulfonates; Cell Proliferation; Cell Survival; Diphenylamine; Drug Resistance, Neoplasm; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Humans; Inhibitory Concentration 50; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute; MAP Kinase Kinase 1; Niacinamide; Oligonucleotide Array Sequence Analysis; Phenylurea Compounds; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; Pyridines; Signal Transduction; Sorafenib; Transcriptome; Tumor Cells, Cultured	2012
Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: a rationale for combination with radiation therapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2012, Volume: 105, Issue:1 Topics: Angiogenesis Inducing Agents; Animals; Apoptosis; Benzamides; Blotting, Western; Diphenylamine; Electron Spin Resonance Spectroscopy; Fibrosarcoma; Glutathione; Liver Neoplasms, Experimental; Mice; Neoplasms, Experimental; Niacinamide; Oxygen Consumption; Phenylurea Compounds; Protein Kinase Inhibitors; Radiation Tolerance; Sorafenib	2012
Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma. Molecular cancer therapeutics, 2013, Volume: 12, Issue:9 Topics: Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; Diphenylamine; Disease Models, Animal; Dogs; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Hemangiosarcoma; Humans; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Niacinamide; Phenylurea Compounds; Signal Transduction; Sorafenib; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2013
Oncogene mimicry as a mechanism of primary resistance to BRAF inhibitors. Cell reports, 2014, Aug-21, Volume: 8, Issue:4 Topics: Animals; Antineoplastic Agents; Apoptosis; Autocrine Communication; Benzamides; Cell Line, Tumor; Cell Survival; Diphenylamine; Drug Resistance, Neoplasm; Female; Humans; Interleukin-6; MAP Kinase Signaling System; Mice, Nude; Mitogen-Activated Protein Kinases; Mutation, Missense; Niacinamide; Oncogenes; Phenylurea Compounds; Proto-Oncogene Proteins B-raf; Sorafenib; Xenograft Model Antitumor Assays	2014
Inhibition of acquired-resistance hepatocellular carcinoma cell growth by combining sorafenib with phosphoinositide 3-kinase and rat sarcoma inhibitor. The Journal of surgical research, 2016, Volume: 206, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diphenylamine; Drug Resistance, Neoplasm; Heterocyclic Compounds, 3-Ring; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Sorafenib	2016
Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase-Driven Leukemias and Other Malignancies. Cancer research, 2017, 10-15, Volume: 77, Issue:20 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Female; HL-60 Cells; Humans; K562 Cells; Leukemia, Myeloid, Acute; MAP Kinase Signaling System; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Random Allocation; Sorafenib; Xenograft Model Antitumor Assays	2017
A biomaterial screening approach reveals microenvironmental mechanisms of drug resistance. Integrative biology : quantitative biosciences from nano to macro, 2017, Dec-11, Volume: 9, Issue:12 Topics: Animals; Antineoplastic Agents; Benzamides; Biocompatible Materials; Cell Communication; Cell Line, Tumor; Diphenylamine; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Extracellular Matrix; Female; Humans; Hydrogels; Hydrogen; Linear Models; MAP Kinase Kinase Kinases; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Niacinamide; Phenylurea Compounds; Phosphoproteins; Phosphorylation; Plastics; Sorafenib; Spheroids, Cellular; Systems Biology; Transcriptome; Tumor Microenvironment	2017